IRS' IP Pricing In Medtronic Case Untenable, Witness Says
The pricing method the IRS has argued Medtronic should have employed when licensing intangible property to its Puerto Rican affiliate doesn't withstand scrutiny, a witness for the corporation said Monday, contending...To view the full article, register now.
Already a subscriber? Click here to view full article